Table 1. Canine patient characteristics.
Variable | Group 1 (intent to treat) (n = 31) | Group 2 (vaccinated) (n = 19) | Group 3 (control) (n = 64) | P-value (Group 2 vs. 3) |
Age (yrs; mean ± SD) | 8.03 (2.7) | 7.6 (2.7) | 7.33 (2.7) | 0.73 |
Body weight (kg; mean ± SD) | 32.9 (13.5) | 33.1 (12.7) | 32.3 (13.1) | 0.82 |
Stage | n (%) | n (%) | n (%) | 0.43 |
II–IV | 17 (54.8%) | 9 (47.4%) | 27 (42.2%) | |
V | 14 (45.2%) | 10 (52.6%) | 37 (57.8%) | |
Sub-stage | n (%) | n (%) | n (%) | 0.112 |
a | 21 (67.7%) | 14 (73.7%) | 35 (54.7%) | |
b | 10 (32.3%) | 5 (26.3%) | 29 (45.3%) | |
Immunophenotype | n (%) | n (%) | n (%) | 0.45 |
B | 21 (67.7%) | 14 (73.7%) | 33 (78.6%) | |
T | 10 (32.3%) | 5 (26.3%) | 9 (21.4%) |